Table 1.
Dataset | Contributors | cell phenotypes | No. of annotations |
Total no. of annotations |
||
---|---|---|---|---|---|---|
Training + Validation | Testing | Training + Validation | Testing | |||
Ovarian T cells | T.G and J.A.L19 | CD4+FOXP3+ | 292 | 197 | 1828 (4 slides) | 997 (5 slides) |
CD4+FOXP3- | 596 | 168 | ||||
PD1+CD8+ | 726 | 347 | ||||
PD1-CD8+ | 139 | 203 | ||||
PD1+CD4+ | 39 | 60 | ||||
PD1+CD8-CD4- | 36 | 22 | ||||
LUSC T cells | T.M, A.U.A, and J.L.Q | CD4+FOXP3+ | 746 | 228 | 2407 (2 slides) | 1383 (2 slides) |
CD4+FOXP3- | 1225 | 696 | ||||
CD8+ | 204 | 200 | ||||
Haematoxylin-stained | 232 | 259 | ||||
DCIS FOXP3 | F.S and E.S.H20 | FOXP3+ | 1030 | 576 | 11,459 (7 slides) | 3799 (5 slides) |
FOXP3− | 10,429 | 3223 | ||||
Myeloma | Y.H, C.S.Y.L, D.P, L.L, M.R-J and K.Y21 | CD8+ | 866 | 979 | 3269 (4 slides) | 1588 (2 slides) |
CD4+FOXP3− | 2244 | 493 | ||||
CD4+FOXP3+ | 159 | 116 | ||||
IMC CD4-CD8 | Damond et al.22 | CD4+ | 987 | 828 | 3954 (80 slides) | 1085 (20 slides) |
CD8+ | 2967 | 257 |